Mumtada Medical Company Enters Major
Collaboration With Mass General Brigham
RIYADH,
Saudi Arabia, May 14, 2024
/PRNewswire/ -- Leaders in Medicine, Government, Business and
Technology attended the 10th Edition of the C3
International Saudi-American Healthcare Forum (SAHF) at the Ritz
Carlton, Riyadh.
The mission of the SAHF 2024 healthcare forum was to honor and
advance research, investment and innovation under the theme:
Building Today's Global Healthcare Systems Deploying
Tomorrow's Technology with the goal of fostering and
promoting healthcare diplomacy.
Organized under the Patronage of the Saudi Ministry of Health
and in cooperation with the King Faisal Specialist Hospital and
Research Centre, the SAHF included partners and speakers from
leading U.S. and Saudi hospitals representing: The Cleveland
Clinic; Mass General Brigham; Memorial Sloan Kettering Cancer
Center; King Faisal Specialist Hospital and Research Centre, HOPE
Rehabilitation Center, and SEHA Virtual Hospital.
A major highlight of the SAHF was the signing of the Mumtada
Medical Company collaboration agreement with Mass General Brigham
to advance specialized rehabilitation and long-term post-acute care
in Saudi Arabia. The Mumtada
Medical Company is a specialized rehabilitation and long-term
post-acute care (LTPAC) company founded by prominent business
leader Fawaz Alhokair. Aligned with Saudi
Arabia's Vision 2030 healthcare transformation its goal is
to provide accessible, high-quality healthcare and to enhance the
local workforce.
Mass General Brigham, based in Boston, U.S.A, was selected as the collaboration
partner to advise on Mumtada Medical Company's inaugural
rehabilitation hospital in Riyadh.
It will be named the Mumtada Rehabilitation Hospital with plans to
launch in 2024, accommodating 200 beds, 27 specialized clinics and
17 dialysis units. Additional facilities across KSA are under
development. This collaboration represents a significant
milestone in addressing the growing demand and need for
comprehensive rehabilitation and LTPAC services in the region.
Throughout the 1-day SAHF gathering, prominent speakers from
major healthcare related businesses, research and investment were
represented by Cigna Insurance; Auxmedge Global Healthcare;
PURELIFE Health Sciences Group; Lamassu Pharma; Zoi Capita; EMIR;
Seedford Partners; the Sultan Bin Abdulaziz Humanitarian City
Research and Scientific Center; and, the Center For The Fourth
Industrial Revolution (C4IR, KSA).
The 2024 Saudi-American Healthcare Forum brought together
leading experts to identify the major healthcare challenges facing
the US and Arab populations. A focus of the SAHF was on how they
can work together to find realistic solutions based on bilateral
collaboration and knowledge transfer. With a goal to identify ways
to bring these major healthcare innovations to fruition in the
region and the global market. Discussion topics covered a wide
range of cutting-edge healthcare and new technology subjects in AI;
cybersecurity; medical tourism; a new protocol to manage Autism;
"Smart Hospitals," advances in mental healthcare; investing in
Sudi Arabia's biotech Sector;
children's health and more.
Concluding SAHF2024 was a new product pitch competition hosted
by Blossom Accelerator, where five finalists were selected to
present their new business ideas to a panel of healthcare and
business investment experts. The winner awarded a cash prize of
25,000 Saudi Riyals to support the development their new
business.
To learn more about the Saudi-American Healthcare Forum 2024,
please visit https://sahf2024.com/ or contact: Dareen Kabbush at +1-917-742-9941 or
377627@email4pr.com.
For more information, please visit https://xs-conferences.com/
or https://c3summit2023nyc.com/.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/under-the-patronage-of-the-ministry-of-health-2024-saudi-american-healthcare-forum-achieves-major-advances-at-xs-conferences--c3-summit-international-forum-302144564.html
SOURCE XS Conferences & C3 Summit International